RIPK1 and Alzheimer disease: Examination of postmortem samples of AD patients revealed significantly higher levels of RIPK1 in comparison to control ones and it was inversely proportional to brain weight as well as cognitive score (Caccamo et al. 2017; Ofengeim et al. 2017).